revista boller 2
TRANSCRIPT
![Page 1: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/1.jpg)
![Page 2: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/2.jpg)
![Page 3: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/3.jpg)
REPRESENTA
![Page 4: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/4.jpg)
![Page 5: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/5.jpg)
Casa Bolleren Oncología
![Page 6: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/6.jpg)
Casa Bolleren Oncología
![Page 7: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/7.jpg)
Casa Bolleren Oncología
![Page 8: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/8.jpg)
Casa Bolleren Oncología
![Page 9: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/9.jpg)
![Page 10: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/10.jpg)
![Page 11: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/11.jpg)
![Page 12: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/12.jpg)
![Page 13: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/13.jpg)
Casa Bolleren Oncología
![Page 14: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/14.jpg)
Casa Bolleren Oncología
![Page 15: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/15.jpg)
Casa Bolleren Oncología
![Page 16: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/16.jpg)
Casa Bolleren Oncología
![Page 17: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/17.jpg)
![Page 18: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/18.jpg)
![Page 19: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/19.jpg)
![Page 20: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/20.jpg)
56%
En pacientes con cáncer de mama matastásicocon diagnóstico Her2/neu+
trastuzumab
®
40%
60%
40% de incremento en la sobrevida frente al uso de paclitaxel solo
56% de diferencia en las tasas de respuesta
60% de incremento en el tiempo hasta la progresión
REPRESENTA
![Page 21: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/21.jpg)
Casa Bolleren Oncología
![Page 22: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/22.jpg)
Casa Bolleren Oncología
![Page 23: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/23.jpg)
Casa Bolleren Oncología
30
![Page 24: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/24.jpg)
Casa Bolleren Oncología
![Page 25: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/25.jpg)
![Page 26: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/26.jpg)
![Page 27: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/27.jpg)
REPRESENTA
![Page 28: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/28.jpg)
![Page 29: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/29.jpg)
Casa Bolleren Oncología
![Page 30: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/30.jpg)
Casa Bolleren Oncología
![Page 31: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/31.jpg)
Casa Bolleren Oncología
![Page 32: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/32.jpg)
Casa Bolleren Oncología
![Page 33: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/33.jpg)
Casa Bolleren Oncología
![Page 34: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/34.jpg)
Casa Bolleren Oncología
![Page 35: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/35.jpg)
Casa Bolleren Oncología
![Page 36: Revista Boller 2](https://reader035.vdocuments.site/reader035/viewer/2022062710/55a011e41a28ab5a108b456d/html5/thumbnails/36.jpg)